Home
Anavex Life Sciences AVXL paid Forbes-Tate $40K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q1 2026
- Client
- Anavex Life Sciences
- Reported
- 26/04/17
Down 33.3% from last quarter
What else happened in Anavex Life Sciences around then
Filed or reported within 30 days of the trade day · 03/01~04/30Anavex Life Sciences's other lobbying reports
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 01/18
for Q4 2025
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 25/10/19
for Q3 2025
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 25/07/18
for Q2 2025
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 25/04/18
for Q1 2025